deaths (OS)

mGC or mGEJC - L1 - HER2 negative metastatic/advanced mGC or mGEJC mGC or mGEJC - 1st line (L1) mGC or mGEJC - L1 - HER2 negative

versus Standard of Care (SoC)
nivolumab plus SoC vs. Standard of Care (SoC) 1 0.80 [0.68; 0.94], 1 RCT, I2=0% conclusive
unassessable degree of certainty